BusinessCURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXAug 22, 2017, 3:19 PM UTC
BusinessHealthLynked Corp. Announces Creation of its Florida Provider NetworkBy Nasdaq OMXAug 21, 2017, 9:00 AM UTC
BusinessGlobus Medical Announces FDA 510(k) Clearance for Excelsius GPS™By Nasdaq OMXAug 17, 2017, 1:13 PM UTC
BusinessRedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release CapsulesBy Nasdaq OMXAug 17, 2017, 11:00 AM UTC
BusinessHealthLynked Corp. Announces Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 15, 2017, 11:22 AM UTC
BusinessOncoCyte Confirms Launch Plans for Lung Cancer Diagnostic Test; Reports Progress Toward CLIA Lab Licensing and Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 14, 2017, 8:10 PM UTC
BusinessEarth Science Tech, Inc. Receives Update from Leading Independent Equity Research & Corporate Firm, SeeThruEquity with a Price Target of $4.12By Nasdaq OMXAug 10, 2017, 12:45 PM UTC
